Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine Augmentation of CET for Smoking Cessation
NCT04035603Phase 2Withdrawn
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 2 trial of d-cycloserine in Tobacco Use Disorder (TUD). Planned start Oct 2020; status: withdrawn.
02
Drugs
d-cycloserine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04035603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04035603.